Shivalik Rasayan Limited (SHIVALIK.BO)
- Previous Close
559.45 - Open
555.20 - Bid 568.10 x --
- Ask 570.60 x --
- Day's Range
555.15 - 582.00 - 52 Week Range
498.00 - 890.05 - Volume
1,431 - Avg. Volume
4,026 - Market Cap (intraday)
8.839B - Beta (5Y Monthly) 1.05
- PE Ratio (TTM)
59.73 - EPS (TTM)
9.51 - Earnings Date May 27, 2024 - May 31, 2024
- Forward Dividend & Yield 0.50 (0.09%)
- Ex-Dividend Date Sep 22, 2023
- 1y Target Est
--
Shivalik Rasayan Limited produces and sells chemicals for the protection of plants in India. The company offers Dimethoate technical, which is used in the preparation of formulations for use in the control of various insects and mites; and Malathion technical, an organophosphorus based contact insecticide used in the agricultural production of various food/feed crops. It also manufactures organophosphorus-based insecticides and chemicals. In addition, the company develops and manufactures active pharmaceutical ingredients in oncology, ARVs, cardiovascular, metabolic disorders, and immunology; and manufactures oncology and non-oncology products. Further, the company offers custom manufacturing of chemicals. Shivalik Rasayan Limited was incorporated in 1979 and is based in New Delhi, India. Shivalik Rasayan Limited is a subsidiary of Growel Remedies Limited.
www.shivalikrasayan.com256
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: SHIVALIK.BO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SHIVALIK.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SHIVALIK.BO
Valuation Measures
Market Cap
8.71B
Enterprise Value
8.66B
Trailing P/E
58.89
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.13
Price/Book (mrq)
2.35
Enterprise Value/Revenue
3.28
Enterprise Value/EBITDA
19.97
Financial Highlights
Profitability and Income Statement
Profit Margin
5.30%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
2.64B
Net Income Avi to Common (ttm)
139.94M
Diluted EPS (ttm)
9.51
Balance Sheet and Cash Flow
Total Cash (mrq)
667.21M
Total Debt/Equity (mrq)
12.41%
Levered Free Cash Flow (ttm)
--
Company Insights: SHIVALIK.BO
SHIVALIK.BO does not have Company Insights